MODULARCMC Trademark
Trademark Overview
On Friday, June 27, 2025, a trademark application was filed for MODULARCMC with the United States Patent and Trademark Office. The USPTO has given the MODULARCMC trademark a serial number of 99256867. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, May 26, 2026. This trademark is owned by Wheeler Bio, Inc.. The MODULARCMC trademark is filed in the Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; development of pharmaceuticals, biopharmaceuticals, pharmaceutical preparations, medicines, pharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical consulting and research services in the field of pharmaceuticals; consultation in the field of pharmaceutical drug delivery and dosage technologies; custom design and development of chemical reagents and biochemical assays; Biotechnology research; Chemical research; research and development services in the field of antibodies being antibody technology; biotechnology research and development services for others, namely, mammalian cell line development and therapeutic antibody de...
Manufacture of pharmaceuticals and biopharmaceuticals to the order and specification of others; biomanufacturing for others, namely, manufacturing of biological products using biological organisms in the manufacturing process for the purpose of facilitating drug development; manufacturing services for others in the fields of mammalian cell line development and therapeutic antibody development; Manufacturing process consulting; contract manufacturing services of biopharmaceuticals, namely, antibodies and recombinant proteins utilizing mammalian cell culture to the order and specification of others; manufacturing services for others in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development
Business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; Business management services, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, supply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; Invoicing services; Order fulfillment services; customer services in the nature of responding to customer inquiries for others in the field of pharmaceutical product distribution and logistics; inventory control services, namely, computerized business record management of pharmaceutical business data; inventory management in the field of pharmaceuticals and pharmaceutical p...
General Information
| Serial Number | 99256867 |
| Word Mark | MODULARCMC |
| Filing Date | Friday, June 27, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | Tuesday, June 16, 2026 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; development of pharmaceuticals, biopharmaceuticals, pharmaceutical preparations, medicines, pharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical consulting and research services in the field of pharmaceuticals; consultation in the field of pharmaceutical drug delivery and dosage technologies; custom design and development of chemical reagents and biochemical assays; Biotechnology research; Chemical research; research and development services in the field of antibodies being antibody technology; biotechnology research and development services for others, namely, mammalian cell line development and therapeutic antibody development; development and analysis services relating to the use of mammalian cell cultures in the field of biotechnology; providing medical and scientific technology research information in the field of pharmaceuticals and biopharmaceuticals, including discovery, preclinical, and clinical drug research and development; toxicological safety testing services for pharmaceuticals and biopharmaceuticals; pharmaceutical contract development in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development; laboratory testing services in clinical research and clinical trials of innovator medicines in the pharmaceutical and biotechnology fields; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical and biopharmaceutical drug development; analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of pharmaceutical and biopharmaceutical drug evaluation and development |
| Goods and Services | Manufacture of pharmaceuticals and biopharmaceuticals to the order and specification of others; biomanufacturing for others, namely, manufacturing of biological products using biological organisms in the manufacturing process for the purpose of facilitating drug development; manufacturing services for others in the fields of mammalian cell line development and therapeutic antibody development; Manufacturing process consulting; contract manufacturing services of biopharmaceuticals, namely, antibodies and recombinant proteins utilizing mammalian cell culture to the order and specification of others; manufacturing services for others in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development |
| Goods and Services | Business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; Business management services, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, supply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; Invoicing services; Order fulfillment services; customer services in the nature of responding to customer inquiries for others in the field of pharmaceutical product distribution and logistics; inventory control services, namely, computerized business record management of pharmaceutical business data; inventory management in the field of pharmaceuticals and pharmaceutical products; computerized tracking and tracing of packages in transit; electronic customer ordering services for pharmaceuticals, pharmaceutical products, medical products and equipment, laboratory supplies and equipment |
| Pseudo Mark | MODULAR CMC |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 27, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, October 25, 2024 |
| First Use In Commerce Date | Friday, October 25, 2024 |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 27, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | Friday, October 25, 2024 |
| First Use In Commerce Date | Friday, October 25, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 27, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, October 25, 2024 |
| First Use In Commerce Date | Friday, October 25, 2024 |
Trademark Owner History
| Party Name | Wheeler Bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Oklahoma City, OK 73102
US |
Trademark Events
| Event Date | Event Description |
| Friday, June 27, 2025 | NEW APPLICATION ENTERED |
| Friday, June 27, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 4, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 17, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, November 18, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 18, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 4, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, February 4, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, May 15, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 15, 2026 | TEAS AMENDMENT OF USE RECEIVED |
| Friday, May 15, 2026 | USE AMENDMENT FILED |
| Friday, May 15, 2026 | AMENDMENT TO USE PROCESSING COMPLETE |
| Monday, May 18, 2026 | USE AMENDMENT ACCEPTED |
| Monday, May 18, 2026 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Friday, May 15, 2026 | TEAS AMENDMENT OF USE RECEIVED |
| Friday, May 15, 2026 | USE AMENDMENT FILED |
| Friday, May 15, 2026 | AMENDMENT TO USE PROCESSING COMPLETE |
